Loading...

Ascletis Pharma Inc.

ASCLF•PNK
Healthcare
Biotechnology
$2.19
$-0.16(-6.83%)
U.S. Market opens in 2h 9m

Ascletis Pharma Inc. (ASCLF) Stock Overview

Explore Ascletis Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.3B
P/E Ratio-41.21
EPS (TTM)$-0.05
ROE-0.19%
Fundamental Analysis

AI Price Forecasts

1 Month$2.20
3 Months$2.31
1 Year Target$2.88

ASCLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ascletis Pharma Inc. (ASCLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -41.21 and a market capitalization of 2.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.83%
5-Day Change
-10.04%
1-Month Change
21.27%
3-Month Change
25.43%
6-Month Change
82.92%
Year-to-Date (YTD) Change
47.32%
1-Year Change
150.09%
3-Year Change
545.59%
5-Year Change
493.24%
All-Time (Max) Change
265.83%

Contact Information

https://www.ascletis.com
86 571 8538 9730
Building D, Hangzhou, NaN, NaN

Company Facts

231 Employees
IPO DateNov 19, 2019
CountryCN
Actively Trading

Frequently Asked Questions